HPS Pharmacies wish to give notice that Mylan Australia is experiencing a supply interruption for ciprofloxacin IV as follows:
Ciprofloxacin Alphapharm Injection
Other brands of this product are also experiencing a short-term supply interruption. Ciprofloxacin injection for intravenous infusion is still available in a 200mg/100mL presentation.
Normal supplies of Ciprofloxacin Alphapharm Injection 400mg/200mL are expected to resume by 20th February 2020. Normal supplies of DBL™ Ciprofloxacin Injection for Intravenous Infusion 400mg/200ml are expected to resume by 10th February 2020.
Retain this notice in a prominent position, including in other related business units until supplies return to normal. Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please contact Mylan Australia on 1800 274 276 or your pharmacist at HPS Pharmacies.
Subscribe Knowledge Centre Updates
Enter your details to receive Knowledge Centre updates